✦ LIBER ✦

Breast cancer in 2013: Genomics, drug approval, and optimal treatment duration

✍ Scribed by Lee, Adrian V.; Davidson, Nancy E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Advances in Cancer Research] Genomics i

✍ Milsted, R.A.V. 📂 Article 📅 2006 🏛 Elsevier ⚖ 146 KB

Neoadjuvant Therapy as a Platform for Dr

✍ Bardia, A.; Baselga, J. 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 503 KB

Genomic approaches in the management and

✍ Chang, J C; Hilsenbeck, S G; Fuqua, S A W 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 145 KB

Genomic Predictors of Outcome and Treatm

✍ Dunn, Lara; DeMichele, Angela 📂 Article 📅 2009 🏛 Springer-Verlag 🌐 English ⚖ 207 KB

Optimal approach in early breast cancer:

✍ Ribeiro, J.; Sousa, B.; Cardoso, F. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 429 KB

The Optimal Duration of Adjuvant Endocri

✍ Johnston, Stephen R. D.; Yeo, Belinda 📂 Article 📅 2014 🏛 Current Science Inc. 🌐 English ⚖ 260 KB